Martin J. Driscoll, President and CEO at Spring Bank Pharmaceuticals, Inc. (SBPH), bought 2,000 shares at $8.50 ($17K) on 2016-12-15, disclosed to the SEC on 2016-12-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| SBPH | BUY | 2019-05-29 | $60K | — | Filing → |
| SBPH | BUY | 2019-05-22 | $33K | — | Filing → |
| SBPH | BUY | 2019-04-30 | $73K | — | Filing → |